| Wnt5a修饰的bMSCs对白血病小鼠造血及白血病细胞生长的影响 |
| |
| 引用本文： | 沈亚莉,徐酉华,顾晓艳. Wnt5a修饰的bMSCs对白血病小鼠造血及白血病细胞生长的影响[J]. 中国肿瘤临床, 2011, 38(14): 811-816. DOI: 10.3969/j.issn.1000-8179.2011.14.001 |
| |
| 作者姓名： | 沈亚莉 徐酉华 顾晓艳 |
| |
| 作者单位： | 重庆医科大学儿童发育疾病研究省部共建教育部重点实验室,重庆医科大学附属儿童医院血液肿瘤科 (重庆市400014) |
| |
| 基金项目： | 本文课题受国家自然科学基金，重庆市卫生局医学科技计划 |
| |
| 摘 要： | 探讨Wnt5a基因修饰的骨髓间充质干细胞（bMSCs）对急性髓系白血病小鼠体内造血和白血病细胞生长的影响。方法:外周血瑞氏染色、骨髓流式细胞仪鉴定移植性HL60人白血病重度联合免疫缺陷(SCID)小鼠模型。造模成功的SCID小鼠，随机分为实验组（A组:Ad5-Wnt5a-bMSCs+模型小鼠）；对照组（B组:Ad5-GFP-bMSC+模型小鼠；C组:bMSC+模型小鼠；D组:模型小鼠）。RT-PCR检测外源性Wnt5a基因经骨髓腔移植入白血病小鼠模型后的定植情况。骨髓MSC及CFU-Mix培养、流式细胞仪、组织细胞化学及组织病理检测白血病小鼠移植前后各组外周血、骨髓、肝、脾、肾中的白血病细胞以及骨髓造血的变化。结果:成功建立急性髓性白血病模型；外源性Wnt5a基因转染人bMSCs，转染率达37.38%。外源性Wnt5a基因成功定植于受体骨髓中。Wnt5a基因修饰bMSCs移植后,与对照组比较，实验组SCID小鼠生存率明显提高，差异有统计学意义（P<0.05）；外周血有核细胞及瘤细胞计数明显降低，差异有统计学意义（P<0.05）；CFU-Mix和MSC集落生长恢复较快，集落数明显增多，差异有统计学意义（P<0.05）；小鼠骨髓、肺、肝、脾、肾CD33阳性率明显降低，差异有统计学意义（P<0.05）。结论:Wnt5a基因修饰的bMSCs在体内能有效地抑制白血病细胞生长,支持骨髓造血。
|
| 关 键 词： | Wnt5a基因修饰的bMSCs 骨髓移植 白血病动物模型 HL60 |
| 收稿时间： | 2011-03-21 |
Effect of Wnt5a-Modified bMSCs on Hematopoiesis and on the Growth of Leukemia Cells in Leukemia Mice |
| |
| Yali SHEN,Youhua XU,Xiaoyan GU. Effect of Wnt5a-Modified bMSCs on Hematopoiesis and on the Growth of Leukemia Cells in Leukemia Mice[J]. Chinese Journal of Clinical Oncology, 2011, 38(14): 811-816. DOI: 10.3969/j.issn.1000-8179.2011.14.001 |
| |
| Authors: | Yali SHEN Youhua XU Xiaoyan GU |
| |
| Affiliation: | The Key Laboratory Constructed by the Ministry of Education and Child Development Diseases, Institute of Chongqing Medical University, Haematological Oncology Department, Affiliated Children's Hospital , Chongqing Medical University, Chongqing 400014, China |
| |
| Abstract: | To investigate the effect of the Wnt5a-modified bone mesenchymal stem cells (bMSCs) on hemopoiesis and leukemic cell growth of mice with acute myeloid leukemia. Methods: A human leukemia model with severe combined immunodeficiency (SCID) was intravenously inoculated with HL60 cells. Wright staining on the peripheral blood and identification using a bone marrow flow cytometry were performed. The well-modeled mice were divided into four groups: the experimental group (Group A, Ad5-Wnt5a-bMSCs + model mice) and the control groups (Group B, Ad5-GFP-bMSC+ model mice; Group C, bMSC+ model mice; and Group D, model mice).The exogenous Wnt5a-modified bMSCs were transplanted into the leukemia mouse model through the marrow cavity, and the colonization was detected using RT-PCR . Changes in the leukemia cells and marrow hemopoiesis in peripheral blood, bone marrow, liver, spleen, and kidney before and after transplantation were determined using histocytochemistry, RT-PCR, flow cytometry, histopathology, bone marrow MSC, and CFU-Mix culture. Results: A model of acute myeloid leukemia was successfully established. The exogenous Wnt5a gene was successfully transfected into bMSCs at a transfer rate of 36.8% and into the bone marrow of the receptors. After the transplantation, the SCID mice in the experimental group exhibited significantly higher survival rates ( P < 0.05 ) and significantly lower nucleated cell and tumor cell counts in the peripheral blood ( P < 0.05 ) compared to the control group. Furthermore, the CFU-Mix and MSC colony growth and recovery were faster. The number of colonies was significantly higher ( P < 0.05 ), and the positive rate of CD33 expression in the bone marrow, lung, liver, spleen, and other organs in the experimental group was considerably lower ( P < 0.05 ). Conclusion: The Wnt5a-modified bMSCs can effectively inhibit the growth of leukemia cells in vivo and support bone marrow hemopoiesis.? |
| |
| Keywords: | HL60 |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《中国肿瘤临床》浏览原始摘要信息 |
|
点击此处可从《中国肿瘤临床》下载免费的PDF全文 |
|
